TrialJournal of clinical pharmacology2018

Exposure-Response (Efficacy) Analysis of Daclatasvir and Asunaprevir in Japanese Patients With Hepatitis C Virus Infection.

Takayo Ueno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.